Jin‐Ku Lee

Medicine · Health Sciences

23h-index2.8kcitations70works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(16), Glioma Diagnosis and Treatment(11), Cytokine Signaling Pathways and Interactions(7), Cancer Genomics and Diagnostics(5), Cancer, Hypoxia, and Metabolism(4)

Publications70 total

The impact of clinical sample collection timing on FRα expression and mirvetuximab soravtansine patient outcomes in the MIRASOL (GOG 3045/ENGOT-ov55) trial
International Journal of Gynecological Cancer·2026
Systematic growth factor profiling platform for 3D tumor models reveals estradiol-responsive cellular mechanisms of immunotherapy resistance
Biofabrication·2025
Systematic Growth Factor Profiling Platform for 3D Tumor Models Reveals Estradiol-Responsive Cellular Mechanisms of Immunotherapy Resistance
2025Open Access
In silico framework about prediction of collagen-derived matrikine generation and its ligand function binding to integrin $$\upalpha _{\textrm{M}}\upbeta _{2}$$ for malignancy of colon cancer
In Silico Pharmacology·2025Open Access
Polyunsaturated Fatty Acids and Skin Cancer: Two-Sample Mendelian Randomization Study
Annals of Dermatology·2025Open Access
expHRD: an individualized, transcriptome-based prediction model for homologous recombination deficiency assessment in cancer
BMC Bioinformatics·2024· 4 citedOpen Access
Empowering pancreatic tumor homing with augmented anti-tumor potency of CXCR2-tethered CAR-NK cells
Molecular Therapy Oncology·2024· 18 citedOpen Access
Development of a novel ex-vivo anticancer drug screening system for precision medicine in ovarian cancer patients
2024Open Access
The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling
JCI Insight·2023· 14 citedOpen Access
Abstract 762: Organo-on-pillar based anticancer drug screening platform for ovarian cancer
Cancer Research·2023
Data from STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
2023Open Access
Data from STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
2023Open Access
Supplementary Figures 1-8 from STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
2023Open Access
Supplementary Figures 1-8 from STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
2023Open Access
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5
Neoplasia·2023· 29 citedOpen Access
High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing
Biomaterials·2023· 15 cited
Unraveling the Transcriptomic Signatures of Homologous Recombination Deficiency in Ovarian Cancers
Advanced Biology·2022· 8 cited
Advanced and Application of Onsite EEW Technology in Korea
Journal of The Korean Society of Disaster Information·2020Open Access
Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target
Experimental & Molecular Medicine·2020Open Access
Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
Scientific Reports·2020· 27 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

K. Jason(15), Yong Jae Shin(14), Do‐Hyun Nam(13), Woong‐Yang Park(11), Raúl Rabadán(11), Hyun Ju Kang(10), Jeongwu Lee(10), Do‐Hyun Nam(10), Yun Jee Seo(9), Yeri Lee(9), Jeong‐Won Lee(9), Jeong-Woo Oh(8), Sang‐Kyu Ye(8), Eun Hee Yi(8), Harim Koo(8), Hee Jin Cho(7), E Sun Paik(7), Young‐Jae Cho(7), Tae‐Joong Kim(7), Chel Hun Choi(7)